TY  - JOUR
A1  - Brophy, V H
A1  - Hastings, M D
A1  - Clendenning, J B
A1  - Richter, R J
A1  - Jarvik, G P
A1  - Furlong, C E
T1  - Polymorphisms in the human paraoxonase (PON1) promoter.
Y1  - 2001/02/
N1  - R826886C002
N1  - R826886
JF  - PHARMACOGENETICS
J1  - PHARMACOGENETICS
VL  - 11
IS  - 1
SP  - 77
EP  - 84
ER  - 


TY  - JOUR
A1  - Brophy, V H
A1  - Jampsa, R L
A1  - Clendenning, J B
A1  - McKinstry, L A
A1  - Jarvik, G P
A1  - Furlong, C E
T1  - Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.
Y1  - 2001/06/
N1  - R826886C002
N1  - R826886
N1  - R831709
JF  - AMERICAN JOURNAL OF HUMAN GENETICS
J1  - AM J HUM GENET
J2  - American Journal of Human Genetics
J3  - American Journal of Human Genetics
J4  - American Journal of Human Genetics
VL  - 68
IS  - 6
SP  - 1428
EP  - 1436
ER  - 


TY  - JOUR
A1  - Furlong, C E
A1  - Li, W F
A1  - Brophy, V H
A1  - Jarvik, G P
A1  - Richter, R J
A1  - Shih, D M
A1  - Lusis, A J
A1  - Costa, L G
T1  - The PON1 gene and detoxication.
Y1  - 2000/08/
N1  - R826886C002
N1  - R826886
JF  - NEUROTOXICOLOGY
J1  - NEUROTOXICOLOGY
VL  - 21
IS  - 4
SP  - 581
EP  - 587
ER  - 


TY  - JOUR
A1  - Furlong, C E
A1  - Li, W F
A1  - Richter, R J
A1  - Shih, D M
A1  - Lusis, A J
A1  - Alleva, E 
A1  - Costa, L G
T1  - Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1).
Y1  - 2000/02/
N1  - R826886C002
N1  - R826886
JF  - NEUROTOXICOLOGY
J1  - NEUROTOXICOLOGY
VL  - 21
IS  - 1-2
SP  - 91
EP  - 100
ER  - 


TY  - JOUR
A1  - Li, W F
A1  - Costa, L G
A1  - Richter, R J
A1  - Hagen, T 
A1  - Shih, D M
A1  - Tward, A 
A1  - Lusis, A J
A1  - Furlong, C E
T1  - Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
Y1  - 2000/12/
N1  - R826886C002
N1  - R826886
JF  - PHARMACOGENETICS
J1  - PHARMACOGENETICS
VL  - 10
IS  - 9
SP  - 767
EP  - 779
ER  -